We are live on ! Find out more
ATRC icon

AtriCure

108 hedge funds and large institutions have $834M invested in AtriCure in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 33

32% more capital invested

Capital invested by funds: $630M → $834M (+$204M)

0% more funds holding

Funds holding: 108108 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0.86% less ownership

Funds ownership: 88.82%87.96% (-0.86%)

Holders
108
Holders Change
Holders Change %
0%
% of All Funds
2.47%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
9
Increased
48
Reduced
33
Closed
9
Calls
$345K
Puts
Net Calls
+$345K
Net Calls Change
+$345K

ATRC Hedge Fund Activity: Q2 2018 in Review

108 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2018, worth a combined $834M — up 32% from $630M a quarter earlier.

Fund positioning in ATRC was balanced in Q2 2018: 9 funds opened new positions, 9 closed out, 48 added to existing stakes and 33 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $21.1M. The largest seller was Wellington Management Group, cutting an estimated $30.6M.

  • 108 institutional investors held AtriCure (ATRC) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $834M of AtriCure stock for Q2 2018, up 32% quarter-over-quarter.
  • 9 funds opened new AtriCure positions in Q2 2018 and 9 closed out, a net change of 0 holders.
  • The largest AtriCure buyer in Q2 2018 was T. Rowe Price Associates, an estimated $21.1M added.
  • The largest AtriCure seller in Q2 2018 was Wellington Management Group, an estimated $30.6M sold.

Based on aggregated 13F filings for Q2 2018.